Inventor · disambiguated record
Marian Gindy
Also filed as: GINDY MARIAN · GINDY MARIAN E
12 granted patents·16 pending applications·56 citations·filing 2008–2024
90Inventor score
Files withMERCK SHARP & DOHME9SIRNA THERAPEUTICS INC7MERCK SHARP & DOHME LLC5BARRETT STEPHANIE ELIZABETH1BROWN DUNCAN1
Top patents by PatentIndex Score
28 records- 0193US8835623B2RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2013·Granted Sep 16, 2014·15 cites·20 claims
- 0292US11638754B2HPV vaccineMERCK SHARP & DOHME·Filed 2021·Granted May 2, 2023·2 cites·24 claims
- 0391US8518907B2RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA)BROWN DUNCAN·Filed 2011·Granted Aug 27, 2013·16 cites·17 claims
- 0490US11406706B2Lipid nanoparticle vaccine adjuvants and antigen delivery systemsMERCK SHARP & DOHME·Filed 2020·Granted Aug 9, 2022·2 cites·18 claims
- 0590US10821175B2Lipid nanoparticle vaccine adjuvants and antigen delivery systemsMERCK SHARP & DOHME·Filed 2015·Granted Nov 3, 2020·5 cites·12 claims
- 0689US9850491B2RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2016·Granted Dec 26, 2017·5 cites·15 claims
- 0788US2024247271A1Rna interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (ctnnb1) gene expression using short interfering nucleic acid (sina)SIRNA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0887US9447420B2RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (SINA)SIRNA THERAPEUTICS INC·Filed 2014·Granted Sep 20, 2016·6 cites·39 claims
- 0980US9943490B2Composite flash-precipitated nanoparticlesPRUDHOMME ROBERT K·Filed 2008·Granted Apr 17, 2018·3 cites·15 claims
- 1077US2023030119A1Rna interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (ctnnb1) gene expression using short interfering nucleic acid (sina)SIRNA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1172US11400186B2Drug delivery system for the delivery of antiviral agentsBARRETT STEPHANIE ELIZABETH·Filed 2017·Granted Aug 2, 2022·2 cites·9 claims
- 1270US2023270850A1Hpv vaccineMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 1370US2024376157A1Polynucleotides encoding norovirus vp1 antigens and uses thereofMERCK SHARP & DOHME LLC·Filed 2024·Application pending·0 cites
- 1468US2019330639A1Rna interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (ctnnb1) gene expression using short interfering nucleic acid (sina)SIRNA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1566US11376225B2Composite flash-precipitated nanoparticlesUNIV PRINCETON·Filed 2018·Granted Jul 5, 2022·0 cites·18 claims
- 1666US10246714B2RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2017·Granted Apr 2, 2019·0 cites·23 claims
- 1765US2025352637A1Method for sustained delivery of mrna vaccinesMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 1861US2016317444A1Liposomal Formulations for Allosteric AKT InhibitorsSMITH MICHAEL HUGHES·Filed 2014·Application pending·0 cites
- 1961US2019374468A1Liposomal Formulations for Allosteric AKT InhibitorsMERCK SHARP & DOHME·Filed 2019·Application pending·0 cites
- 2058US2024050378A1Lipid nanoparticle compositions containing monoester cationic lipidsMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 2157US2011022129A1Nanoparticles for photodynamic therapyPRUD HOMME ROBERT K·Filed 2008·Application pending·0 cites
- 2256US2021186867A1Drug delivery system for the delivery of antiviral agentsMERCK SHARP & DOHME·Filed 2021·Application pending·0 cites
- 2352US11419817B2Drug delivery system for the delivery of antiviral agentsMERCK SHARP & DOHME·Filed 2018·Granted Aug 23, 2022·0 cites·12 claims
- 2451US2023310309A1Injectable depot compositions for the delivery of antiviral agentsMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 2550US2019388336A1Drug Delivery System for the Delivery of Antiviral AgentsMERCK SHARP & DOHME·Filed 2017·Application pending·0 cites
- 2640US2013037977A1Preparation of Lipid NanoparticlesBURKE PAUL A·Filed 2011·Application pending·0 cites
- 2740US2019216725A1Drug delivery system for the delivery of integrase inhibitorsMERCK SHARP & DOHME·Filed 2017·Application pending·0 cites
- 2834US2020179273A1Long-action implant for treatment of infectious diseasesMERCK SHARP & DOHME·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marian Gindy files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →